Remineralization Effects of Hydroxyapatite Toothpaste

Sponsor
Dr. Joachim Enax (Industry)
Overall Status
Completed
CT.gov ID
NCT03681340
Collaborator
(none)
32
1
2
9.8
3.3

Study Details

Study Description

Brief Summary

The objective of this in situ clinical study is to determine whether a toothpaste containing hydroxyapatite microclusters is as effective as a fluoridated kid's toothpaste in promoting remineralization of early caries lesions and inhibiting the development of caries lesions.

Condition or Disease Intervention/Treatment Phase
  • Other: Hydroxyapatite toothpaste
  • Other: Fluoridated toothpaste
N/A

Detailed Description

The investigators hypothesize that (1) both the hydroxyapatite and the fluoridated toothpaste promote caries remineralization that is significantly greater than zero, and (2) the two toothpaste formulations are equally effective with respect to post-treatment remineralization and inhibition of demineralization.

  • Non-inferiority will be considered established if there is no statistically significant difference in percentage of remineralization between the hydroxyapatite-containing toothpaste and the fluoridated kid's toothpaste for any one measurement method.

  • Superiority/inferiority will be considered established if at least 20% statistically significant difference is observed between the hydroxyapatite-containing toothpaste and the fluoridated kid's toothpaste for any one measurement method

Study Design

Study Type:
Interventional
Actual Enrollment :
32 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Prevention
Official Title:
Investigation of the Caries Prevention and Remineralization Effects of Hydroxyapatite Toothpaste
Actual Study Start Date :
Aug 7, 2018
Actual Primary Completion Date :
Mar 1, 2019
Actual Study Completion Date :
Jun 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Hydroxyapatite toothpaste

4 weeks toothbrushing with a hydroxyapatite toothpaste

Other: Hydroxyapatite toothpaste
If in a subject a significant increase of carious lesions will be observed, her/his parents are informed about the necessity for further caries preventive measures (e.g. dietary changes, use of fluoride products, reduction of cariogenic microflora with chlorhexidine, xylitol chewing gum, etc.) and caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.

Other: Fluoridated toothpaste
If in a subject a significant increase of carious lesions will be observed, her/his parents are informed about the necessity for further caries preventive measures (e.g. dietary changes, use of fluoride products, reduction of cariogenic microflora with chlorhexidine, xylitol chewing gum, etc.) and caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.

Active Comparator: Fluoridated toothpaste

4 weeks toothbrushing with a fluoridated toothpaste

Other: Hydroxyapatite toothpaste
If in a subject a significant increase of carious lesions will be observed, her/his parents are informed about the necessity for further caries preventive measures (e.g. dietary changes, use of fluoride products, reduction of cariogenic microflora with chlorhexidine, xylitol chewing gum, etc.) and caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.

Other: Fluoridated toothpaste
If in a subject a significant increase of carious lesions will be observed, her/his parents are informed about the necessity for further caries preventive measures (e.g. dietary changes, use of fluoride products, reduction of cariogenic microflora with chlorhexidine, xylitol chewing gum, etc.) and caries preventive treatment (removing caries and placing a restoration) by the study centers is offered.

Outcome Measures

Primary Outcome Measures

  1. Caries remineralization [4 weeks]

    Analyis of mineral gain/loss and lesion depth by microradiography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Male and/or female subjects 18 to 50 years inclusive

  2. Minimum of 20 natural uncrowned teeth (excluding third molars) must be present

  3. Willing to wear retainer 24 hours per day

  4. No active, unrestored cavities

  5. Have normal salivary flow rate (stimulated and unstimulated flow of ≥0.7 ml/min and ≥0.2 ml/min respectively) ascertained from a preliminary sialometry test

  6. Available throughout entire study

  7. Willing to use only assigned products for oral hygiene throughout the duration of the study

  8. Must give written informed consent

  9. Must be in good general health

  10. No known history of allergy to personal care/consumer products or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study

Exclusion Criteria:
  1. Advanced periodontal disease

  2. Medical condition which requires premedication prior to dental visits/procedures

  3. Not enough teeth to secure the oral retainer

  4. Diseases of the soft or hard oral tissues

  5. Wearing of an orthodontic retainer(s)

  6. Impaired salivary function

  7. Current use of drugs that can affect salivary flow

  8. Use of antibiotics one (1) month prior to or during this study

  9. Positive urine test for pregnancy or self-reported breastfeeding. A urine pregnancy test will be performed on female subjects of child-bearing potential.

  10. Participation in another clinical study one (1) week prior to the start of the washout period or during this study period

  11. Use of tobacco products

  12. Allergic history to common toothpaste ingredients

  13. Allergic history to amino acids

  14. Immune compromised individuals (HIV, AIDS, immuno-suppressive drug therapy) as determined by review of medical history

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78229-3900

Sponsors and Collaborators

  • Dr. Joachim Enax

Investigators

  • Principal Investigator: Bennett T. Amaechi, Prof., The University of Texas Health Science Center at San Antonio

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Joachim Enax, Senior Scientist, Dr. Kurt Wolff GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT03681340
Other Study ID Numbers:
  • REHT18
First Posted:
Sep 24, 2018
Last Update Posted:
Jul 22, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 22, 2019